Join BOPA
Back to news articles

Early career pharmacy researcher award (OPERA 2025)

By BOPA Committee on 4th December 2024

My name is Zita Zachariah and I am the Managing Editor of the Royal Pharmaceutical Society research journals. I am reaching out since we felt that the members of the British Oncology Pharmacy Association may be interested to know that nominations for next year’s award OPERA2025 have now opened.

The OPERA award was launched in 2022 to celebrate contributions by up-and-coming researchers to the advancement of the science of medicines and clinical pharmacy. All shortlisted candidates for the OPERA award will be featured in the Pharmaceutical Journal and so this is a valuable platform for early career researchers to gain visibility in the pharmacy community.

OPERA nominations are

  • open to all UK based early-career pharmacy practice/pharmaceutical sciences/health services researchers,
  • all applications will be anonymised before judging and
  • self-nominations are welcome.

For more information see the link below

pharmaceutical-journal.com-Nominate an outstanding early-career pharmacy researcher for OPERA 2025

Best Regards

Zita

Latest News

By BOPA Committee on 22nd January 2025

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications

NIHR INSIGHT Programme South London Research Masters Studentships 2025/26: Call for applications is now open. For more info click here and/or see flyer below.  

Read article
By BOPA research committee on 22nd January 2025

SURVEY: Examining barriers to pharmacy professionals engaging with research

The Incubator for Pharmacy Professionals is an NIHR-supported initiative dedicated to strengthening research capacity within the pharmacy profession. Despite its critical role as a pillar of professional practice, research remains…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA Committee on 20th January 2025

UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…

Read article